Expression of LOX in Colorectal Cancer Tissues and Its Relationship with Progress and Prognosis

SHI Xiao-ming, ZHAO Wei, YANG Yong-bin. et al

Abstract

To analyze the expression of lysyl oxidase (LOX) in colorectal cancer and its relationship with clinicopathological characteristics, prognosis, and its progress. Methods 82 cases of colorectal tumor paraffin-embedded specimens and paired tumor-adjacent tissues were collected, and data of clinicopathological characteristics and prognosis of these patients were also recorded from 2009.1 to 2010.5. Expressions of LOX, hypoxia inducible factor-1α (HIF-1α), matrix metalloproteinase (MMP)-2, MMP-7 were determined by immunohistochemistry. Then relationship between LOX and clinicopathological characteristics and prognosis was explored, and relationship between LOX and HIF-1α, MMP-2, MMP-7 were investigated. Results Expressions of LOX was stronger in tumors than in tumor-adjacent tissues (P<0.05). Cancer tissues with overexpressed LOX had later clinical stages, deeper tumor invasion, and more metastatic lymph nodes (all P<0.05). The result also showed that patients with overexpression of LOX had poorer prognosis, and overexpression of LOX was independent factor for prognosis in COX survival analysis. Expression of HIF-1α, MMP-2, MMP-7 in colorectal cancer was stronger than in tumor-adjacent tissues (P<0.05). Positive relationship was found between LOX and HIF-1α, MMP-2, MMP-7 proteins (P<0.05). Conclusion LOX was overexpressed in colorectal cancer tissues, and was associated with the progression of colorectal cancer. LOX may be involved in the progress of colorectal cancer by regulating HIF-1α, MMP-2, MMP-7 protein expression.

 

Keywords: Colorectal cancer, Lysyl oxidase (LOX) gene, Clinicopathological characteristics, Prognosis, Invasion, metastasis  

 

Full Text:

PDF


References


MILLER BW, MORTON JP. PINESE M. et al. Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Mol Med,2015. 7(8):1063-1076.

LIU J, PING W, ZU Y, et al. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non¬small cell lung cancer. Int J Clin Exp Pathol ,2014 ,7( 9) ;6040- 6047.

KIM HY.CHO HK, YOO SK, et al. Hepatic STAMP2 deceases hepatitis В virus X protein-associated metabolic deregulation. Exp Mol Med.2012,44(10); 622-632.

KIM KH. SHIN HJ, KIM K, et al. Hepatitis В virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterolory, 2007, 132 (5);1955-1967.

LAI H. JIN Q, LIN Y, et al. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer. Tumour Biol,2014 ,35( 10) : 10547-10554.

GAO X, ZHANG S, ZHU Z. Lysyl oxidase rsl800449 polymorphism and cancer risk among Asians: evidence from a meta-analysis and a case-control study of colorectal cancer. Mol Genet Genomics,2015 »290( 1) :23-28.

PERRYMAN L. ERLER JT. Lysyl oxidase in cancer research. Future Oncol,2014 ,10(9): 1709-1717. PAPADANTONAKIS N, MATSUURA S, RAVID K. Megakaryocyte pathology and bone marrow fibrosis; the lysyl oxidase connection. Blood.2012,120(9); 1774-1781.

JI F, WANG Y, QIU L, et al. Hypoxia inducible factor la- mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer. Int J Oncol, 2013, 42 (5):1578-1588.

AGRA N, CIDRE F, GARCIA-GARCIA L, et al. Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells. PLoS One, 2013, 8 ( 6): e66281 [2016- 10-07]. http;//doi. org/10. 1371/journal, pone. 0066281.

WANG Y, MA J, SHEN H, et al. Reactive oxygen species promote ovarian cancer progression via the HIF-la/LOX/E- cadherin pathway. Oncol Rep,2014 ,32(5);2150-2158.

LIU JL, WEI W. TANG W. et al. Silencing of lysyl oxidase gene expression by RNA interference suppresses metastasis of breast cancer. Asian Рас J Cancer Prev,2012,13(7);3507- 3511.


Refbacks

  • There are currently no refbacks.